High Court Pay-For-Delay Ruling To Revamp Drug Patent Deals
The U.S. Supreme Court's Monday ruling allowing antitrust challenges to pay-for-delay settlements will reshape how drugmakers settle patent disputes, attorneys say, since the court stressed that a generics maker will have...To view the full article, register now.
Already a subscriber? Click here to view full article